Scientific resource
Poster

NANOCYCLIX® ALK2 INHIBITORS TO OVERCOME CANCER INDUCED ANEMIA
NANOCYCLIX® ALK2 INHIBITORS TO OVERCOME CANCER INDUCED ANEMIA

Novel fluorescent probes evaluated in an orthotopic pancreatic PDX model
Novel fluorescent probes evaluated in an orthotopic pancreatic PDX model

Bioanalytical challenges with BioChaperone® BC structures
We wish to develop and validate LC-MS/MS methods for the quantitation of both BioChaperone® BCXXX (Parent) and its truncated metabolite BCYYY inSprague-Dawley rat, Beagle dog and human plasma following the current international guidelines for industry?

Quantitative Targeted Absolute Proteomics (QTAP) analysis of transporters for the validation of an in vitro Blood Brain Barrier model
We used Quantitative Targeted Absolute Proteomics (QTAP) basedmultiplexed MRM4-5 to evaluate the protein expression levels of ten selectedtransporters in the hBMEC BBB model.

Nanocyclix: next generation kinase therapeutics A chemocentric approach for the discovery of selective kinase inhibitors
Nanocyclix: next generation kinase therapeuticsA chemocentric approach for the discovery of selective kinase inhibitors